Elderly patients undergoing hip fracture surgery Surgery
Conditions
Interventions
FICB+SPB group: With the patient in the supine position, standard skin disinfection were performed. A high-frequency linear array transducer (S-Nerve, SonoSite Inc., USA) was placed perpendicular to t
Sponsors
Dongyang People's Hospital
Eligibility
Sex/Gender
All
Age
65 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with first hip fracture confirmed by computed tomography and X-ray 2. Age =65 years 3. American Society of Anesthesiologists (ASA) physical status II–III 4. Provided written informed consent after fully understanding the anesthesia procedures, potential complications, and related precautions
Exclusion criteria
Exclusion criteria: 1. Multiple fractures, such as pathological fractures, pelvic fractures, femur fractures 2. Long-term use of analgesic medications 3. Contraindications to peripheral nerve blocks, such as allergy to local anaesthetics, infection at the puncture site, lumbar degenerative disease, coagulopathy or bleeding disorders 4. Severe dysfunction of vital organs, including the cardiovascular or cerebrovascular systems 5. History of neurological, psychiatric disorders, or cognitive impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Hemodynamic response to surgical stress: Mean arterial pressure (MAP), systolic blood pressure (SBP), heart rate (HR), and oxygen saturation (SpO2) were continuously monitored using standard noninvasive monitors. Measurements were recorded at six standardized timepoints:T0: Before anesthesia; T1: At the time of skin incision; T2: 30 minutes after the start of surgery; T3: During key surgical steps; T4: At the end of surgery; T5: Upon leaving the operating room 2. Severity of postoperative pain: Pain intensity was assessed using the Visual Analog Scale (VAS, 0–10; 0 = no pain, 10 = worst pain imaginable). Pain was evaluated both at rest and during passive limb movement at 3, 6, 12, 18, and 24 hours postoperatively. Movement pain assessment: Passive mobilization was performed by gently elevating the injured limb approximately 15° | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Postoperative sufentanil consumption is measured using cumulative dosage recorded from patient-controlled analgesia (PCA) device at 3, 6, 12, 18, and 24 hours postoperatively 2. Length of hospital stay is measured using electronic medical records at discharge 3. Anesthesia-related complications are measured using clinical observation and documentation in patient charts during the intraoperative and postoperative period until discharge 4. Mean arterial pressure (MAP) is measured using non-invasive blood pressure monitoring at T0 (before anesthesia), T1 (skin incision), T2 (30 minutes after surgery began), T3 (during key surgical steps), T4 (end of surgery), and T5 (upon leaving the operating room) 5. Systolic blood pressure (SBP) is measured using non-invasive blood pressure monitoring at T0, T1, T2, T3, T4, and T5 6. Heart rate (HR) is measured using electrocardiographic monitoring at T0, T1, T2, T3, T4, and T5 7. Peripheral capillary oxygen saturation (SpO2) is measured using pulse oximetry at T0, T1, T2, T3, T4, and T5 8. Postoperative pain at rest is measured using the Visual Analog Scale (VAS, 0–10) at 3, 6, 12, 18, and 24 hours postoperatively 9. Postoperative pain during passive movement is measured using the Visual Analog Scale (VAS, 0–10) during elevation of the injured limb approximately 15° at 3, 6, 12, 18, and 24 hours postoperatively | — |
Countries
China
Contacts
Public ContactMin Wang
Outcome results
None listed